Journal of Vascular Surgery
Volume 46, Issue 4 , Pages 682-686 , October 2007

The role of tissue factor in patients undergoing open repair of ruptured and nonruptured abdominal aortic aneurysms

  • Simon D. Hobbs, MBChB

      Affiliations

    • University Department of Vascular Surgery, Heart of England National Health Service Foundation Trust, Birmingham, UK
    • ,
  • Paul Haggart, MD

      Affiliations

    • University Department of Vascular Surgery, Heart of England National Health Service Foundation Trust, Birmingham, UK
    • ,
  • Chris Fegan, MD

      Affiliations

    • University Department of Haematology, Heart of England National Health Service Foundation Trust, Birmingham, UK.
    • ,
  • Andrew W. Bradbury, MD

      Affiliations

    • University Department of Vascular Surgery, Heart of England National Health Service Foundation Trust, Birmingham, UK
    • ,
  • Donald J. Adam, MD

      Affiliations

    • University Department of Vascular Surgery, Heart of England National Health Service Foundation Trust, Birmingham, UK
    • Corresponding Author InformationReprint requests: Donald J. Adam, University Department of Vascular Surgery, Heart of England NHS Foundation Trust, Netherwood House, Solihull Hospital, Birmingham B91 2JL, UK.

Received 21 February 2007 ,Accepted 23 May 2007.

References 

  1. Adam DJ, Ludlam CA, Ruckley CV, Bradbury AW. Coagulation and fibrinolysis in patients undergoing operation for ruptured and nonruptured infrarenal abdominal aortic aneurysms. J Vasc Surg. 1999;30:641–650
  2. Adam DJ, Haggart PC, Ludlam CA, Bradbury AW. Coagulopathy and hyperfibrinolysis in ruptured abdominal aortic aneurysm repair. Ann Vasc Surg. 2004;18:572–577
  3. Garcia-Fernandez N, Lavilla FJ, Rocha E, Purroy A. Haemostatic changes in systemic inflammatory response syndrome during continuous renal replacement therapy. J Nephrol. 2000;13:282–289
  4. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med. 2003;31:S213–S220
  5. Gando S. Tissue factor in trauma and organ dysfunction. Semin Thromb Hemost. 2006;32:48–53
  6. Laterre PF, Wittebole X, Collienne C. Pharmacological inhibition of tissue factor. Semin Thromb Hemost. 2006;32:71–76
  7. Yamazumi K, Ojiro M, Okumura H, Aikou T. An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm. Am J Surg. 1998;175:297–301
  8. Nomura F, Ihara A, Yoshitatsu M, Tamura K, Katayama A, Ihara K. Relationship between coagulation cascade, cytokine, adhesion molecule and aortic aneurysm. Eur J Cardiothorac Surg. 2003;23:1034–1038discussion 1038-9
  9. Gando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O. Tissue factor and tissue factor pathway inhibitor levels during and after cardiopulmonary resuscitation. Thromb Res. 1999;96:107–113
  10. Gando S, Nanzaki S, Morimoto Y, Ishitani T, Kemmotsu O. Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients. Crit Care Med. 2001;29:262–266
  11. Haggart PC, Adam DJ, Ludman PF, Ludman CA, Bradbury AW. Myocardial injury and systemic fibrinolysis in patients undergoing repair of ruptured abdominal aortic aneurysm. European Journal of Vascular & Endovascular Surgery. 2001;21:529–534
  12. Bouma BN, Mosnier LO. Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis. Pathophysiol Haemost Thromb. 2003;33:375–381
  13. Paola Cellai A, Antonucci E, Alessandrello Liotta A, Fedi S, Marcucci R, Falciani M, et al. TAFI activity and antigen plasma levels are not increased in acute coronary artery disease patients admitted to a coronary care unit. Thromb Res. 2006;118:495–500
  14. Zeerleder S, Schroeder V, Hack CE, Kohler HP, Wuillemin WA. TAFI and PAI-1 levels in human sepsis. Thromb Res. 2006;118:205–212
  15. Chen CC, Lee KD, Gau JP, Yu YB, You JY, Lee SC, et al. Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation. Ann Hematol. 2005;84:675–680
  16. Levi M, van der Poll T, ten Cate H. Tissue factor in infection and severe inflammation. Semin Thromb Hemost. 2006;32:33–39

 Competition of interest: none.

PII: S0741-5214(07)00988-3

doi: 10.1016/j.jvs.2007.05.057

Journal of Vascular Surgery
Volume 46, Issue 4 , Pages 682-686 , October 2007

Article Tools

* Image Usage & Resolution